Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts - PubMed (original) (raw)
Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts
L H Blumgart et al. Lancet. 1984.
Abstract
Analysis of the surgical management of 94 consecutive patients with carcinoma at the confluence of the hepatic ducts showed that 20% of them (or 60% of those thought, after comprehensive pre-operative investigation, to have resectable lesions) underwent tumour resection--6 local resections and 12 liver resections. The 30-day hospital mortality was 11% and mean duration of survival was 17 months (7 patients are still alive, with a mean survival of 22.2 months). The quality of life was also much improved after resection. In patients treated with palliative surgery the hospital mortality was 33% and the mean survival was 8.5 months. The results support the treatment of bile-duct carcinoma at the hilum of the liver by resection and suggest that the use of drainage techniques, whether employed surgically or non-surgically, be reserved until the possibility of treatment by resection has been fully considered.
Similar articles
- Surgical resection for cholangiocarcinoma involving the confluence of the major hepatic ducts.
Strong RW. Strong RW. Aust N Z J Surg. 1987 Dec;57(12):911-5. doi: 10.1111/j.1445-2197.1987.tb01293.x. Aust N Z J Surg. 1987. PMID: 2449886 - The role of U tube palliative treatment in high bile duct carcinoma.
Terblanche J, Kahn D, Bornman PC, Werner D. Terblanche J, et al. Surgery. 1988 Jun;103(6):624-32. Surgery. 1988. PMID: 2453935 - Outcome of radical surgery in hilar cholangiocarcinoma.
Hadjis NS, Blenkharn JI, Alexander N, Benjamin IS, Blumgart LH. Hadjis NS, et al. Surgery. 1990 Jun;107(6):597-604. Surgery. 1990. PMID: 2162082 - Liver resection for bile duct cancer.
Blumgart LH, Benjamin IS. Blumgart LH, et al. Surg Clin North Am. 1989 Apr;69(2):323-37. doi: 10.1016/s0039-6109(16)44789-4. Surg Clin North Am. 1989. PMID: 2538936 Review. - Klatskin tumours.
Burcharth F. Burcharth F. Acta Chir Scand Suppl. 1988;541:63-9. Acta Chir Scand Suppl. 1988. PMID: 2455407 Review.
Cited by
- Rifampicin as cytotoxic agent for cholangiocarcinoma: preliminary report of seven cases.
Sali A, McQuillan T, Read A, Kune G. Sali A, et al. J Cancer Res Clin Oncol. 1991;117(6):503-4. doi: 10.1007/BF01613278. J Cancer Res Clin Oncol. 1991. PMID: 1660477 - Surgical palliation of proximal malignant biliary obstruction.
Wilson RH, Johnston GW, Moorehead RJ. Wilson RH, et al. Ulster Med J. 1992 Apr;61(1):45-50. Ulster Med J. 1992. PMID: 1377842 Free PMC article. No abstract available. - Induction of DNA replication and cell growth in rat liver by obstructive jaundice.
Terasaki M, Kuriki H, Nimura Y, Shionoya S, Kojima K, Yoshida S. Terasaki M, et al. Jpn J Cancer Res. 1991 Feb;82(2):170-5. doi: 10.1111/j.1349-7006.1991.tb01825.x. Jpn J Cancer Res. 1991. PMID: 1900821 Free PMC article. - Resection or palliation: priority of surgery in the treatment of hilar cancer.
Bismuth H, Castaing D, Traynor O. Bismuth H, et al. World J Surg. 1988 Feb;12(1):39-47. doi: 10.1007/BF01658484. World J Surg. 1988. PMID: 2449769 No abstract available. - Large hepatocellular cancers: hepatic resection or liver transplantation?
Søreide O, Czerniak A, Blumgart LH. Søreide O, et al. Br Med J (Clin Res Ed). 1985 Sep 28;291(6499):853-7. doi: 10.1136/bmj.291.6499.853. Br Med J (Clin Res Ed). 1985. PMID: 2996689 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical